These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32694940)

  • 1. Correction to: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
    Hu Y; Xie H; Liu Y; Liu W; Liu M; Tang H
    Cancer Cell Int; 2020; 20():318. PubMed ID: 32694940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
    Hu Y; Xie H; Liu Y; Liu W; Liu M; Tang H
    Cancer Cell Int; 2017; 17():36. PubMed ID: 28286418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction Note to: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
    Hu Y; Xie H; Liu Y; Liu W; Liu M; Tang H
    Cancer Cell Int; 2021 May; 21(1):255. PubMed ID: 33971879
    [No Abstract]   [Full Text] [Related]  

  • 5. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1.
    Li J; Xia L; Zhou Z; Zuo Z; Xu C; Song H; Cai J
    Arch Biochem Biophys; 2018 Feb; 640():53-60. PubMed ID: 29325758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-486-5p suppresses TGF-β2-induced proliferation, invasion and epithelial-mesenchymal transition of lens epithelial cells by targeting Smad2.
    Liu B; Sun J; Lei X; Zhu Z; Pei C; Qin L
    J Biosci; 2017 Dec; 42(4):575-584. PubMed ID: 29229876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 promotes cell metastasis in cervical cancer through modulating epithelial-mesenchymal transition.
    Tang Y; Zhao Y; Ran J; Wang Y
    Oncol Lett; 2020 Apr; 19(4):3289-3295. PubMed ID: 32256824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.
    Huang CM; Huang CS; Hsu TN; Huang MS; Fong IH; Lee WH; Liu SC
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861383
    [No Abstract]   [Full Text] [Related]  

  • 19. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.
    Pan Y; Zhang J; Fu H; Shen L
    Onco Targets Ther; 2016; 9():6247-6255. PubMed ID: 27785072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.